Barinthus Biotherapeutics (BRNS) Current Deferred Revenue (2020 - 2026)
Barinthus Biotherapeutics (BRNS) recorded Current Deferred Revenue of $335,000 in Q2 2026, down 78.0% from $1.53 million a year earlier but up 5.3% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics reported Current Deferred Revenue of $1.4 million, down 19.7% from FY2024.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of 41.6% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $1.74 million in FY2024 and $182,000 in FY2021 (-25.7%).
- Quarterly Current Deferred Revenue has ranged from $111,000 in Q3 2022 to $2.04 million in Q3 2024 over the past five years.
- On a year-over-year basis, Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 20.6% over the last six quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 81.8% in Q2 2025, against a decline of 78.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $318,000 (Q1 2026), $1.4 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 335,000.00 |
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 839,000.00 |
| Mar 31, 2024 | 1.43 Mn |
| Sep 30, 2022 | 111,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Mar 31, 2022 | 162,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 196,000.00 |
| Jun 30, 2021 | 217,000.00 |
| Mar 31, 2021 | 346,000.00 |
| Dec 31, 2020 | 245,000.00 |
API Access
Barinthus Biotherapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();